Vita Therapeutics Raises $32 Million in Oversubscribed Series A Financing Led by Cambrian Biopharma to Advance the Development of Therapies to Treat Muscular Dystrophies

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3wVOHNu
via IFTTT